Phagelux Inc., of Shanghai, appointed Rong Chen global chief medical officer. Chen has more than 25 years of experience in pharmaceutical drug development, including extensive knowledge of global clinical trials and regulatory approvals. He will be responsible for global drug development and global regulatory approvals. In addition, as part of the management team, Chen will be instrumental in determining and implementing a product development strategy and will additionally be involved in certain business development activities.
Roche AG, of Basel, Switzerland, appointed Christiane Hamacher head of Asia Pacific (APAC), part of its global pharmaceutical leadership team. Hamacher was most recently general manager of the company’s Czech Republic business, and has established a strong track record in strategic management and human resources, including global commercial and operational roles in the U.S., Europe and Asia. She will be based in Singapore.